Ariad Pharmaceuticals Inc fka ARIA

[lax20m]

Well at least we agree on this. We need to stick to our guns. Our pricing is consistent with an orphan drug in the space. Our drug is highly highly effective and is a life line for those with the T315i mutation. Until our label allows us to market to other lines the price is appropriate in the context of the industry. Say what one will about the drugs safety profile if you have the t315i mutation it's a miracle life line.

Should enough data be analyzed to safely move it to the second line then a price reduction would be appropriate.

I think there is some merit in criticizing the drug industry and its pricing. However I'm still befuddled why one would target an unprofitable biotech that has a drug that is saving peoples lives. If a company can't recoup their costs they would not develop orphan drugs. Maybe Bernie should investigate why it costs so much to develop drugs. If we could being that price down then selling prices could be decreased. Deny a company the ability to recoup their cost means they won't be in business. This isn't Pfizer and we aren't making billions on pills that help get an erection